| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 207 | 81 | 203 | - | - |
| Total Income - EUR | - | - | - | - | - | 207 | 81 | 203 | - | - |
| Total Expenses - EUR | - | - | - | - | - | 0 | 14 | 0 | - | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | 207 | 67 | 203 | - | - |
| Net Profit/Loss - EUR | - | - | - | - | - | 201 | 64 | 198 | - | - |
| Employees | - | - | - | - | - | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Aseptiq Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Current Assets | - | - | - | - | - | 248 | 303 | 507 | - | - |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Cash | - | - | - | - | - | 248 | 303 | 507 | - | - |
| Shareholders Funds | - | - | - | - | - | 242 | 301 | 499 | - | - |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | - | - |
| Debts | - | - | - | - | - | 6 | 2 | 7 | - | - |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2041 - 2041" | |||||||||
| CAEN Financial Year |
2041
|
|||||||||
Comments - Aseptiq Lab S.r.l.